These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 31777562)
21. Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma. Wu G; Wang Q; Zhu T; Fu L; Li Z; Wu Y; Zhang C Front Genet; 2021; 12():681277. PubMed ID: 34306024 [TBL] [Abstract][Full Text] [Related]
22. Identification of a RNA-Seq Based Prognostic Signature with Seven Immune-Related lncRNAs for Lung Adenocarcinoma. You J; Fang W; Zhao Q; Chen L; Chen L; Chen F Clin Lab; 2021 Mar; 67(3):. PubMed ID: 33739047 [TBL] [Abstract][Full Text] [Related]
23. Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma. Liu J; Liu Q; Shen H; Liu Y; Wang Y; Wang G; Du J Front Genet; 2022; 13():838624. PubMed ID: 35928454 [TBL] [Abstract][Full Text] [Related]
24. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer. Fan Q; Liu B Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307 [TBL] [Abstract][Full Text] [Related]
25. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma. Zhao QJ; Zhang J; Xu L; Liu FF World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881 [TBL] [Abstract][Full Text] [Related]
26. Molecular characterization of lung adenocarcinoma: A potential four-long noncoding RNA prognostic signature. Sui J; Yang S; Liu T; Wu W; Xu S; Yin L; Pu Y; Zhang X; Zhang Y; Shen B; Liang G J Cell Biochem; 2019 Jan; 120(1):705-714. PubMed ID: 30125988 [TBL] [Abstract][Full Text] [Related]
27. A novel signature based on autophagy-related lncRNA for prognostic prediction and candidate drugs for lung adenocarcinoma. Gong Z; Li Q; Li J; Xie J; Wang W Transl Cancer Res; 2022 Jan; 11(1):14-28. PubMed ID: 35261881 [TBL] [Abstract][Full Text] [Related]
28. Identification and verification of a prognostic ferroptosis-related lncRNAs signature for patients with lung adenocarcinoma. Qi K; Liu XL; Chen XL; Song C; Peng JH; Xu JJ Am J Transl Res; 2022; 14(6):3698-3715. PubMed ID: 35836852 [TBL] [Abstract][Full Text] [Related]
29. Identification and Validation of a Ferroptosis-Related Long Non-coding RNA Signature for Predicting the Outcome of Lung Adenocarcinoma. Zheng Z; Zhang Q; Wu W; Xue Y; Liu S; Chen Q; Lin D Front Genet; 2021; 12():690509. PubMed ID: 34367250 [TBL] [Abstract][Full Text] [Related]
30. A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD). Al-Dherasi A; Huang QT; Liao Y; Al-Mosaib S; Hua R; Wang Y; Yu Y; Zhang Y; Zhang X; Huang C; Mousa H; Ge D; Sufiyan S; Bai W; Liu R; Shao Y; Li Y; Zhang J; Shi L; Lv D; Li Z; Liu Q Cancer Cell Int; 2021 Jun; 21(1):294. PubMed ID: 34092242 [TBL] [Abstract][Full Text] [Related]
31. An Immune-Related lncRNA Expression Profile to Improve Prognosis Prediction for Lung Adenocarcinoma: From Bioinformatics to Clinical Word. Zhang B; Wang R; Li K; Peng Z; Liu D; Zhang Y; Zhou L Front Oncol; 2021; 11():671341. PubMed ID: 33968781 [TBL] [Abstract][Full Text] [Related]
32. A novel senescence-related lncRNA signature that predicts prognosis and the tumor microenvironment in patients with lung adenocarcinoma. Fang X; Huang E; Xie X; Yang K; Wang S; Huang X; Song M Front Genet; 2022; 13():951311. PubMed ID: 36406130 [No Abstract] [Full Text] [Related]
33. Identification of a Novel Prognostic Signature of Genome Instability-Related LncRNAs in Early Stage Lung Adenocarcinoma. Peng B; Li H; Na R; Lu T; Li Y; Zhao J; Zhang H; Zhang L Front Cell Dev Biol; 2021; 9():706454. PubMed ID: 34336859 [TBL] [Abstract][Full Text] [Related]
34. Identification and Validation of a Novel Six-lncRNA-Based Prognostic Model for Lung Adenocarcinoma. Yang L; Wu Y; Xu H; Zhang J; Zheng X; Zhang L; Wang Y; Chen W; Wang K Front Oncol; 2021; 11():775583. PubMed ID: 35111670 [TBL] [Abstract][Full Text] [Related]
35. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer. Zhou M; Guo M; He D; Wang X; Cui Y; Yang H; Hao D; Sun J J Transl Med; 2015 Jul; 13():231. PubMed ID: 26183581 [TBL] [Abstract][Full Text] [Related]
36. Four long noncoding RNAs act as biomarkers in lung adenocarcinoma. Zhang Z; Yang L; Li Y; Wu Y; Li X; Wu X Open Med (Wars); 2021; 16(1):660-671. PubMed ID: 33981850 [TBL] [Abstract][Full Text] [Related]
37. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients. Fan Q; Liu B J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531 [TBL] [Abstract][Full Text] [Related]
38. Differential expression analysis at the individual level reveals a lncRNA prognostic signature for lung adenocarcinoma. Peng F; Wang R; Zhang Y; Zhao Z; Zhou W; Chang Z; Liang H; Zhao W; Qi L; Guo Z; Gu Y Mol Cancer; 2017 Jun; 16(1):98. PubMed ID: 28587642 [TBL] [Abstract][Full Text] [Related]
39. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma. Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459 [TBL] [Abstract][Full Text] [Related]
40. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]